CMV-hspCas9-T2A-Puro-H1-gRNA
To Order Contact us: bjorn@lembcke.dk
CMV-hspCas9-T2A-Puro-H1-AAVS1 gRNA SmartNuclease Pre-Packaged Lentiviral Particles [>10^6 IFUs] |
|||
| CASLV601VA-1 | SBI | 2 x 25ul | EUR 836.4 |
EF1-hspCas9-H1-gRNA SmartNuclease vector |
|||
| CAS900A-1 | SBI | 10 ug | EUR 966 |
CAG-hspCas9-H1-gRNA SmartNuclease vector |
|||
| CAS920A-1 | SBI | 10 ug | EUR 966 |
MSCV-hspCas9-H1-gRNA SmartNuclease vector |
|||
| CAS960A-1 | SBI | 10 ug | EUR 966 |
PGK-hspCas9-H1-gRNA SmartNuclease vector |
|||
| CAS980A-1 | SBI | 10 ug | EUR 966 |
Cas9 Nickase: CMV-T7-hspCas9-nickase-T2A-GFP-H1-gRNA linearized SmartNickase vector |
|||
| CAS790G-1 | SBI | 10 rxn | EUR 1005.6 |
Cas9 Nickase: CMV-T7-hspCas9-nickase-T2A-RFP-H1-gRNA linearized SmartNickase vector |
|||
| CAS791R-1 | SBI | 10 rxn | EUR 1005.6 |
CMV-T7-hspCas9-H1-gRNA linearized SmartNuclease vector |
|||
| CAS740A-1 | SBI | 10 rxn | EUR 966 |
Multiplex gRNA Kit + CMV-T7-hspCas9-H1-gRNA linearized SmartNuclease vector |
|||
| CAS740A-KIT | SBI | 10 rxn | EUR 1358.4 |
Cas9 Nickase: CMV-hspCas9(D10A)-T2A-Puro-H1-gRNA linearized all-in-one SmartNuclease Lentivector Plasmid |
|||
| CASLV400PA-1 | SBI | 10 rxn | EUR 966 |
Cas9 Nickase: CMV-hspCas9-nickase-H1-gRNA SmartNickase vector |
|||
| CAS840A-1 | SBI | 10 ug | EUR 966 |
Cas9 Nickase: EF1-T7-hspCas9-nickase-T2A-GFP-H1-gRNA linearized SmartNickase vector |
|||
| CAS750G-1 | SBI | 10 rxn | EUR 1005.6 |
Cas9 Nickase: EF1-T7-hspCas9-nickase-T2A-RFP-H1-gRNA linearized SmartNickase vector |
|||
| CAS751R-1 | SBI | 10 rxn | EUR 1005.6 |
Cas9 Nickase: CAG-T7-hspCas9-nickase-T2A-GFP-H1-gRNA linearized SmartNickase vector |
|||
| CAS770G-1 | SBI | 10 rxn | EUR 1005.6 |
Cas9 Nickase: CAG-T7-hspCas9-nickase-T2A-RFP-H1-gRNA linearized SmartNickase vector |
|||
| CAS771R-1 | SBI | 10 rxn | EUR 1005.6 |
CMV-hspCas9-T2A-Puro SmartNuclease Lentivector Plasmid |
|||
| CASLV100PA-1 | SBI | 10 ug | EUR 836.4 |
Cas9 Nickase: MSCV-hspCas9(D10A)-T2A-Puro-H1-gRNA linearized all-in-one SmartNuclease Lentivector Plasmid |
|||
| CASLV420PA-1 | SBI | 10 rxn | EUR 966 |
Multiplex gRNA Kit + EF1-T7-hspCas9-H1-gRNA linearized SmartNuclease vector |
|||
| CAS700A-KIT | SBI | 10 rxn | EUR 1358.4 |
Multiplex gRNA Kit + CAG-T7-hspCas9-H1-gRNA linearized SmartNuclease vector |
|||
| CAS720A-KIT | SBI | 10 rxn | EUR 1358.4 |
EF1-T7-hspCas9-H1-gRNA linearized SmartNuclease vector |
|||
| CAS700A-1 | SBI | 10 rxn | EUR 966 |
CAG-T7-hspCas9-H1-gRNA linearized SmartNuclease vector |
|||
| CAS720A-1 | SBI | 10 rxn | EUR 966 |
Multiplex gRNA Kit + Cas9 Nickase: CMV-T7-hspCas9-nickase-H1-gRNA linearized SmartNickase vector |
|||
| CAS790A-KIT | SBI | 10 rxn | EUR 1358.4 |
Cas9 Nickase: CMV-T7-hspCas9-nickase-H1-gRNA linearized SmartNickase vector |
|||
| CAS790A-1 | SBI | 10 rxn | EUR 966 |
Cas9 Nickase: EF1-hspCas9-nickase-H1-gRNA SmartNickase vector |
|||
| CAS800A-1 | SBI | 10 ug | EUR 966 |
Cas9 Nickase: CAG-hspCas9-nickase-H1-gRNA SmartNickase vector |
|||
| CAS820A-1 | SBI | 10 ug | EUR 966 |
CMV Control lentiviral particles (Puro) |
|||
| CMV-Null-Puro | GenTarget | 1 x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. |
|||
Cas9 Null Nuclease: EF1-hspCas9-DM-H1-gRNA NullNuclease vector |
|||
| CAS805A-1 | SBI | 10 ug | EUR 966 |
Multiplex gRNA Kit + Cas9 Nickase: EF1-T7-hspCas9-nickase-H1-gRNA linearized SmartNickase vector |
|||
| CAS750A-KIT | SBI | 10 rxn | EUR 1358.4 |
Multiplex gRNA Kit + Cas9 Nickase: CAG-T7-hspCas9-nickase-H1-gRNA linearized SmartNickase vector |
|||
| CAS770A-KIT | SBI | 10 rxn | EUR 1358.4 |
MSCV-hspCas9-T2A-Puro SmartNuclease Lentivector Plasmid |
|||
| CASLV120PA-1 | SBI | 10 ug | EUR 836.4 |
CMV-hspCas9-T2A-Puro SmartNuclease Lentivector Plasmid + LentiStarter Packaging Kit |
|||
| CASLV100PA-KIT | SBI | 1 Kit | EUR 1358.4 |
Cas9 Nickase: CMV-hspCas9(D10A)-T2A-Puro SmartNickase Lentivector Plasmid |
|||
| CASLV200PA-1 | SBI | 10 ug | EUR 836.4 |
Cas9 Nickase: EF1-T7-hspCas9-nickase-H1-gRNA linearized SmartNickase vector |
|||
| CAS750A-1 | SBI | 10 rxn | EUR 966 |
Cas9 Nickase: CAG-T7-hspCas9-nickase-H1-gRNA linearized SmartNickase vector |
|||
| CAS770A-1 | SBI | 10 rxn | EUR 966 |
pGreen- Puro- pSIH1- H1- copGFP- T2A- Puro |
|||
| PVT11116 | Lifescience Market | 2 ug | EUR 444 |
PrecisionX Multiplex gRNA Cloning Kit |
|||
| CAS9-GRNA-KIT | SBI | 10 rxn | EUR 534 |
CMV Control lentiviral particles (Puro) in PBS |
|||
| CMV-Null-Puro-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 852 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
pLenti-EF1伪-DsRed-Monomer-T2A-Puro-U6-gRNA |
|||
| PVT10978 | Lifescience Market | 2 ug | EUR 361.2 |
pmU6- gRNA- CAG- mKate2- T2A- Bsd |
|||
| PVT10974 | Lifescience Market | 2 ug | EUR 361.2 |
CMV-hspCas9-T2A-Puro SmartNuclease Pre-Packaged Lentiviral Particles [>10^6 IFUs] |
|||
| CASLV100VA-1 | SBI | 2 x 25ul | EUR 836.4 |
shRNA-H1 (Neg)-(Puromycin) lentivirus |
|||
| H1(shRNA-Ctr)-Puro | GenTarget | 1 x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a Puromycin marker under Rsv promoter. |
|||
MSCV-hspCas9-T2A-Puro SmartNuclease Lentivector Plasmid + LentiStarter Packaging Kit |
|||
| CASLV120PA-KIT | SBI | 1 Kit | EUR 1358.4 |
Cas9 Nickase: MSCV-hspCas9(D10A)-T2A-Puro SmartNickase Lentivector Plasmid |
|||
| CASLV220PA-1 | SBI | 10 ug | EUR 836.4 |
Cas9 Nickase: CMV-hspCas9(D10A)-T2A-Puro SmartNickase Lentivector Plasmid + LentiStarter Packaging Kit |
|||
| CASLV200PA-KIT | SBI | 1 Kit | EUR 1358.4 |
hTERT (CMV, Puro) lentivirus |
|||
| LVP1130-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Premade lentivirus expressing human TERT gene under suCMV promoter, containing Puromycin marker. |
|||
Cas9 Nickase: CMV-hspCas9(D10A)-T2A-Puro SmartNickase Pre-Packaged Lentiviral Particles [>10^6 IFUs] |
|||
| CASLV200VA-1 | SBI | 2 x 25ul | EUR 836.4 |
CMV-TetR (Puro) Lentiviral particles |
|||
| LVP017-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 484.8 |
|
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under CMV promoter, with Puromycin antibiotic marker. |
|||
MSCV-hspCas9-T2A-Puro SmartNuclease Pre-Packaged Lentiviral Particles [>10^6 IFUs] |
|||
| CASLV120VA-1 | SBI | 2 x 25ul | EUR 836.4 |
shRNA-H1 (Neg)-( GFP-Puro) lentivirus |
|||
| H1(shRNA-Ctr)-GP | GenTarget | 1 x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a GFP-Puromycin fusion marker under Rsv promoter. |
|||
shRNA-H1(Neg)-( RFP-Puro) lentivirus |
|||
| H1(shRNA-Ctr)-RP | GenTarget | 1 x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a RFP-puromycin fusion marker under Rsv promoter. |
|||
Cas9 Nickase: MSCV-hspCas9(D10A)-T2A-Puro SmartNickase Lentivector Plasmid + LentiStarter Packaging Kit |
|||
| CASLV220PA-KIT | SBI | 1 Kit | EUR 1358.4 |
EF1-Blasticidin-H1-gRNA linearized SmartNuclease Lentivector Plasmid |
|||
| CASLV500PA-B | SBI | 10 rxn | EUR 836.4 |
EF1-GFP-H1-gRNA linearized SmartNuclease Lentivector Plasmid |
|||
| CASLV501PA-G | SBI | 10 rxn | EUR 836.4 |
EF1-RFP-H1-gRNA linearized SmartNuclease Lentivector Plasmid |
|||
| CASLV502PA-R | SBI | 10 rxn | EUR 836.4 |
SV40 large T-antigen (Puro), CMV lentiviral particles |
|||
| LVP016-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Pre-made lentiviral particles expressing SV40 large T-antigen under suCMV promoter, containing puromycin marker. |
|||
pMC.CMV-GFP-T2A-Puro-H1-MCS (shRNA expression parental minicircle plasmid) |
|||
| MNSI505A-1 | SBI | 10 ug | EUR 1016.4 |
pMC.EF1-GFP-T2A-Puro-H1-MCS (shRNA expression parental minicircle plasmid) |
|||
| MNSI506A-1 | SBI | 10 ug | EUR 1016.4 |
CMV Control lentiviral particles (GFP-Puro) |
|||
| CMV-Null-GP | GenTarget | 1 x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. |
|||
CMV Control lentiviral particles (RFP-Puro) |
|||
| CMV-Null-RP | GenTarget | 1 x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. |
|||
pCDH- CMV- MCS- EF1- CopGFP- T2A- Puro |
|||
| PVT2333 | Lifescience Market | 2 ug | EUR 390 |
pCDH- CMV- MCS- EF1- turboRFP- T2A- Puro |
|||
| PVT11077 | Lifescience Market | 2 ug | EUR 444 |
pCDH-CMV-GLUT1-EF1-turboRFP-T2A-Puro |
|||
| PVT13588 | Lifescience Market | 2 ug | EUR 718.8 |
pCDH-CMV-Akaluc-EF1-CopGFP-T2A-Puro |
|||
| PVT14490 | Lifescience Market | 2 ug | EUR 718.8 |
Human Histone H1 (H1) ELISA Kit |
|||
| DLR-H1-Hu-48T | DL Develop | 48T | EUR 620.4 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Histone H1 (H1) in samples from tissue homogenates, cell lysates or other biological fluids. |
|||
Human Histone H1 (H1) ELISA Kit |
|||
| DLR-H1-Hu-96T | DL Develop | 96T | EUR 807.6 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Histone H1 (H1) in samples from tissue homogenates, cell lysates or other biological fluids. |
|||
Human Histone H1 (H1) ELISA Kit |
|||
| RD-H1-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 625.2 |
Human Histone H1 (H1) ELISA Kit |
|||
| RD-H1-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 867.6 |
Human Histone H1 (H1) ELISA Kit |
|||
| RDR-H1-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 652.8 |
Human Histone H1 (H1) ELISA Kit |
|||
| RDR-H1-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 907.2 |
pMC.CMV-GFP-T2A-Puro-H1-Scramble (shRNA scramble control parental minicircle plasmid) |
|||
| MNSI000A-1 | SBI | 10 ug | EUR 1016.4 |
Cas9 Nickase: MSCV-hspCas9(D10A)-T2A-Puro SmartNickase Pre-Packaged Lentiviral Particles [>10^6 IFUs] |
|||
| CASLV220VA-1 | SBI | 2 x 25ul | EUR 836.4 |
hTERT (CMV, Puro) lentivirus in PBS |
|||
| LVP1130-Puro-PBS | GenTarget | 1x108 IFU/ml x 200ul | EUR 852 |
|
Description: Concentrated lentivirus in PBS, expressing human TERT gene under suCMV promoter, containing Puromycin marker. |
|||
pLL-CMV-GFP-T2A-Puro [Lenti-LabelerTM plasmid] |
|||
| LL100PA-1 | SBI | 10 ug | EUR 810 |
pLL-CMV-GFP-T2A-Puro [Lenti-LabelerTM virus] |
|||
| LL100VA-1 | SBI | >2x10^6 IFUs | EUR 810 |
pLL-CMV-RFP-T2A-Puro [Lenti-LabelerTM plasmid] |
|||
| LL110PA-1 | SBI | 10 ug | EUR 810 |
pLL-CMV-RFP-T2A-Puro [Lenti-LabelerTM virus] |
|||
| LL110VA-1 | SBI | >2x10^6 IFUs | EUR 810 |
pLL-CMV-BFP-T2A-Puro [Lenti-LabelerTM plasmid] |
|||
| LL120PA-1 | SBI | 10 ug | EUR 810 |
pLL-CMV-BFP-T2A-Puro [Lenti-LabelerTM virus] |
|||
| LL120VA-1 | SBI | >2x10^6 IFUs | EUR 810 |
pLL-CMV-Luciferase-T2A-Puro [Lenti-LabelerTM plasmid] |
|||
| LL150PA-1 | SBI | 10 ug | EUR 810 |
pLL-CMV-Luciferase-T2A-Puro [Lenti-LabelerTM virus] |
|||
| LL150VA-1 | SBI | >2x10^6 IFUs | EUR 810 |
pCDH-CMV-efemp1-m-EF1-CopGFP-T2A-Puro |
|||
| PVT17438 | Lifescience Market | 2 ug | EUR 360 |
pCDH-CMV-TXNL1-HA-EF1-CopGFP-T2A-Puro |
|||
| PVT17693 | Lifescience Market | 2 ug | EUR 309.6 |
pCDH-CMV-CCDC68-HA-EF1-CopGFP-T2A-Puro |
|||
| PVT17760 | Lifescience Market | 2 ug | EUR 309.6 |
pCDH-CMV-ccl3-m-EF1-CopGFP-T2A-Puro |
|||
| PVT19054 | Lifescience Market | 2 ug | EUR 360 |
pCDH-CMV-PTX3-EF1-CopGFP-T2A-Puro Plasmid |
|||
| PVT17116 | Lifescience Market | 2 ug | EUR 390 |
pCDH-CMV-MCS-EF1-copGFP-T2A-Puro plasmid |
|||
| PVT17271 | Lifescience Market | 2 ug | EUR 568.8 |
shRNA-H1 (Neg)-( GFP-Puro) lentivirus in PBS |
|||
| H1(shRNA-Ctr)-GP-PBS | GenTarget | 5 x107 IFU/ml x 200ul | EUR 852 |
|
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a GFP-Puromycin fusion marker under Rsv promoter. Virus was concentrated and provided in PBS solution. |
|||
shRNA-H1(Neg)-( RFP-Puro) lentivirus in PBS |
|||
| H1(shRNA-Ctr)-RP-PBS | GenTarget | 5 x107 IFU/ml x 200ul | EUR 852 |
|
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a RFP-puromycin fusion marker under Rsv promoter. Virus was concentrated and provided in PBS solution. |
|||
CMV-TetR (Puro) Lentiviral particles in PBS |
|||
| LVP017-Puro-PBS | GenTarget | 5x107 IFU/ml x 200ul | EUR 608.4 |
|
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under CMV promoter, with Puromycin antibiotic marker. Particles pellet was re-suspended in PBS solution. |
|||
HEK293-TetR (Puro) |
|||
| SC005-Puro | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1452 |
|
Description: tetracycline repressor in HEK293 stable cell line with Puromycin fusion marker |
|||
Transfection-ready hspCas9-T2A-GFP SmartNuclease mRNA (wildtype Cas9 with GFP marker) |
|||
| CAS530G-1 | SBI | 10 ug | EUR 480 |
Transfection-ready hspCas9-T2A-RFP SmartNuclease mRNA (wildtype Cas9 with RFP marker) |
|||
| CAS531R-1 | SBI | 10 ug | EUR 480 |
hspCas9 AAVS1 Safe Harbor Knock-in Donor (AAVS1-SA-puro-EF1-hspCas9) |
|||
| CAS620A-1 | SBI | 10 ug | EUR 1417.2 |
hspCas9 AAVS1 Safe Harbor Knock-in Donor (AAVS1-SA-puro-EF1-hspCas9) |
|||
| CAS620A-KIT | SBI | 1 kit | EUR 2582.4 |
|
Description: Complete Kit with CAS601A-1 (Cas9 SmartNuclease AAVS1-gRNA Targeting Vector), CAS640PR-1 (Junction PCR Primer Mix to confirm Cas9 integration site), and CAS9-PR-1 (PCR primers to confirm Cas9 expression) |
|||
gRNA- Cloning |
|||
| PVT10957 | Lifescience Market | 2 ug | EUR 361.2 |
pmU6- gRNA |
|||
| PVT10988 | Lifescience Market | 2 ug | EUR 319.2 |
ph7SK- gRNA |
|||
| PVT10989 | Lifescience Market | 2 ug | EUR 319.2 |
phU6- gRNA |
|||
| PVT10990 | Lifescience Market | 2 ug | EUR 319.2 |
phH1- gRNA |
|||
| PVT10991 | Lifescience Market | 2 ug | EUR 319.2 |
pUC119- gRNA |
|||
| PVT11212 | Lifescience Market | 2 ug | EUR 361.2 |
pT7- gRNA |
|||
| PVT11352 | Lifescience Market | 2 ug | EUR 361.2 |
hTERT (EF1a, Puro) lentivirus |
|||
| LVP1131-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Premade lentivirus expressing human TERT gene under EF1a promoter, containing Puromycin marker. |
|||
rtTA (Puro) , Lentiviral particles |
|||
| LVP400-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 484.8 |
|
Description: Pre-made lentiviral particles expressing reverse tetracycline Transcriptional Activator (rtTA) under enhanced EF1a promoter with Puromycin antibioic marker, provided in DMEM medium with 10% FBS. |
|||
CMV Control lentiviral particles (GFP-Puro) in PBS |
|||
| CMV-Null-GP-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 852 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
CMV Control lentiviral particles (RFP-Puro) in PBS |
|||
| CMV-Null-RP-PBS | GenTarget | 1 x108 IFU/ml x 200ul | EUR 852 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter. The virus was concentrated and provided in PBS solution. |
|||
β-Lactamase (Puro) lentiviral particles |
|||
| LVP335-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: pre-made lentiviral particles expressing β-Lactamase gene. A puromycin marker was expressed under RSV promoter. Particles is provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. |
|||
EF1a-TetR (Puro) Lentiviral particles |
|||
| LVP459-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 484.8 |
|
Description: Pre-made lentiviral particles expressing tetracycline regulator protein (TetR) under enhanced EF1a promoter with Puromycin antibioic marker. |
|||
Hela-TetR (Puro) stable cells |
|||
| SC035-Puro | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1452 |
|
Description: tetracycline repressor expression Hela stable cell line with Puromycin marker |
|||
SV40 large T-antigen (Puro) in PBS, CMV lentiviral particles |
|||
| LVP016-Puro-PBS | GenTarget | 5x107 IFU/ml x 200ul | EUR 852 |
|
Description: Pre-made lentiviral particles expressing SV40 large T-antigen under suCMV promoter, containing puromycin marker, provided in PBS solution. |
|||
pCDH-EF1-CymR-T2A-Puro (plasmid) |
|||
| QM200PA-2 | SBI | 10 ug | EUR 716.4 |
pCDH-EF1-CymR-T2A-Puro (virus) |
|||
| QM200VA-2 | SBI | >1 x 10^6 IFUs | EUR 763.2 |
pCDH- EF1- MCS- T2A- Puro Plasmid |
|||
| PVT2335 | Lifescience Market | 2 ug | EUR 390 |
shRNA-H1 (Neg)-(blasticidin) lentivirus |
|||
| H1(shRNA-Ctr)-Bsd | GenTarget | 1 x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a Blasticidin marker under Rsv promoter. |
|||
pLL-CMV-rFLuc-T2A-GFP-mPGK-Puro [Lenti-LabelerTM plasmid] |
|||
| LL310PA-1 | SBI | 10 ug | EUR 836.4 |
pLL-CMV-rFLuc-T2A-GFP-mPGK-Puro [Lenti-LabelerTM virus] |
|||
| LL310VA-1 | SBI | >2x10^6 IFUs | EUR 836.4 |
pLL-CMV-rFLuc-T2A-mRFP-mPGK-Puro [Lenti-LabelerTM plasmid] |
|||
| LL320PA-1 | SBI | 10 ug | EUR 836.4 |
pLL-CMV-rFLuc-T2A-mRFP-mPGK-Puro [Lenti-LabelerTM virus] |
|||
| LL320VA-1 | SBI | >2x10^6 IFUs | EUR 836.4 |
LoxP GFP/RFP ColorSwitch (Puro) lentivirus |
|||
| LVP460-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 852 |
|
Description: Pre-made lentiviral particles expressing "LoxP-GFP-stop-LoxP-RFP-Stop" cassette under suCMV promoter. It also contains a puromycin antibiotic selection marker under Rsv promoter. Virus is provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. |
|||
CMV-hspCas9-EF1-GFP SmartNuclease Lentivector Plasmid |
|||
| CASLV105PA-1 | SBI | 10 ug | EUR 836.4 |
Transfection-ready hspCas9-nickase-T2A-GFP SmartNickase mRNA (Cas9 Nickase mutant with GFP marker) |
|||
| CAS534G-1 | SBI | 10 ug | EUR 480 |
Transfection-ready hspCas9-nickase-T2A-RFP SmartNickase mRNA (Cas9 Nickase mutant with RFP marker) |
|||
| CAS535R-1 | SBI | 10 ug | EUR 480 |
pBPK2101- saCas9- gRNA |
|||
| PVT10927 | Lifescience Market | 2 ug | EUR 361.2 |
pDestTol2pA2-U6-gRNA |
|||
| PVT14656 | Lifescience Market | 2 ug | EUR 718.8 |
SV40 large T-antigen (Puro), EF1a lentiviral particles |
|||
| LVP557-Puro | GenTarget | 1x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Pre-made lentiviral particles expressing SV40 large T-antigen under EF1a promoter, containing puromycin marker. |
|||
MDA-MB-231 / GFP (Puro) Stable Cell Line |
|||
| SC040-Puro | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1452 |
|
Description: GFP expression stable cell line in MDA-MB-231 cells with Puromycin resistance |
|||
MDA-MB-231 / Luciferase (Puro) Stable Cell Line |
|||
| SC059-Puro | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1800 |
|
Description: Luciferase (firefly) expression stable cell line in MDA-MB-231 cells with Puromycin resistance |
|||
shRNA-H1 (Neg)-( GFP-Bsd) lentivirus |
|||
| H1(shRNA-Ctr)-GB | GenTarget | 1 x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a GFP-Blasticidin fusion marker under Rsv promoter. |
|||
shRNA-H1 (Neg)-( RFP-Bsd) lentivirus |
|||
| H1(shRNA-Ctr)-RB | GenTarget | 1 x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Pre-made optional inducible lentiviral shRNA expression particles under human H1 promoter, containing a hairpin insert that should not knockdown any known human or mouse gene. This non-targeting control serves as a negative control for shRNA knockdown experiments. It also contains a RFP-Blasticidin fusion marker under Rsv promoter. |
|||
pGreenFire 2.0-CMV positive control plasmid (pGF2-CMV-rFluc-T2A-GFP-mPGK-Puro) |
|||
| TR410PA-P | SBI | 10 µg | EUR 836.4 |
pGreenFire 2.0-CMV positive control virus (pGF2-CMV-rFluc-T2A-GFP-mPGK-Puro) |
|||
| TR410VA-P | SBI | >2 x 10^6 IFUs | EUR 836.4 |
pCDH-CMV-Piranha-EF1-GFP-T2A-Puro virus (>1x10^6 IFUs) |
|||
| PTPD513VA-1 | SBI | >1x10^6 IFUs | EUR 836.4 |
T2A-GFP Co-Expression HR Targeting Vector [T2A-GFP-pA-loxP-EF1?-RFP-T2A-Puro-pA-LoxP-MCS] |
|||
| HR130PA-1 | SBI | 10 ug | EUR 1227.6 |
pCDH-Cuo-MCS-EF1-CymR-T2A-Puro |
|||
| QM800A-1 | SBI | 10 ug | EUR 1572 |
pCDH- MSCV- MCS- EF1- CopGFP- T2A- Puro |
|||
| PVT11079 | Lifescience Market | 2 ug | EUR 444 |
pCDH-EF1-MCS-T2A-Puro (CD520A) plasmid |
|||
| PVT17273 | Lifescience Market | 2 ug | EUR 568.8 |
copGFP-T2A-Puro-pA OmniTag Minicircle Donor |
|||
| OT501MC-1 | SBI | 10 µg | EUR 709 |
6xHis-T2A-Puro-pA OmniTag Minicircle Donor |
|||
| OT503MC-1 | SBI | 10 µg | EUR 709 |
3xFlag-T2A-Puro-pA OmniTag Minicircle Donor |
|||
| OT504MC-1 | SBI | 10 µg | EUR 709 |
pGreenFire1-CMV Virus (pTRH1 CMV dscGFP T2A Fluc) |
|||
| TR011VA-1 | SBI | >2 x 10^6 IFUs | EUR 943.2 |
Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP (Puro) |
|||
| SC018-Puro | GenTarget | 2x10E6 cell/ml x1ml | EUR 5280 |
|
Description: CRE reporter cell line (Puro): HEK293 cell line expressing "LoxP-GFP-stop-LoxP-RFP" cassette with Puromycin antibiotic marker |
|||
OmniTag F0 Frame Selector Vector with CMV-hspCas9 |
|||
| OT100-F0 | SBI | 10 µg | EUR 709 |
OmniTag F1 Frame Selector Vector with CMV-hspCas9 |
|||
| OT101-F1 | SBI | 10 µg | EUR 709 |
OmniTag F2 Frame Selector Vector with CMV-hspCas9 |
|||
| OT102-F2 | SBI | 10 µg | EUR 709 |
CMV control lentivirus (Hygro) |
|||
| CMV-Null-Hygro | GenTarget | 1 x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the hygromycin selection under RSV promoter. |
|||
CMV control lentivirus (Zeo) |
|||
| CMV-Null-Zeo | GenTarget | 1 x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the Zeocin selection under RSV promoter. |
|||
pBABE-Puro Retroviral Vector |
|||
| RTV-001-PURO | Cell Biolabs | 10 ?g | EUR 679.2 |
|
Description: Use this construct to clone your gene for downstream recombinant retroviral packaging |
|||
pUC57- Simple- gRNA backbone |
|||
| PVT11371 | Lifescience Market | 2 ug | EUR 361.2 |
CMV Control lentiviral particles (Bsd) |
|||
| CMV-Null-Bsd | GenTarget | 1 x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the blasticidin marker under RSV promoter. |
|||
CMV Control lentiviral particles (Neo) |
|||
| CMV-Null-Neo | GenTarget | 1 x107 IFU/ml x 200ul | EUR 418.8 |
|
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter. |
|||
GFP-T2A-Luciferase Co-Expression HR Targeting Vector [GFP-T2A-Luc-pA-loxP-EF1?-RFP-T2A-Puro-pA-LoxP-MCS] |
|||
| HR150PA-1 | SBI | 10 ug | EUR 1227.6 |
pLL-EF1a-GFP-T2A-Puro [Lenti-LabelerTM plasmid] |
|||
| LL200PA-1 | SBI | 10 ug | EUR 810 |
pLL-EF1a-GFP-T2A-Puro [Lenti-LabelerTM virus] |
|||
| LL200VA-1 | SBI | >2x10^6 IFUs | EUR 810 |
pLL-EF1a-RFP-T2A-Puro [Lenti-LabelerTM plasmid] |
|||
| LL210PA-1 | SBI | 10 ug | EUR 810 |
pLL-EF1a-RFP-T2A-Puro [Lenti-LabelerTM virus] |
|||
| LL210VA-1 | SBI | >2x10^6 IFUs | EUR 810 |
pLL-EF1a-BFP-T2A-Puro [Lenti-LabelerTM plasmid] |
|||
| LL220PA-1 | SBI | 10 ug | EUR 810 |
pLL-EF1a-BFP-T2A-Puro [Lenti-LabelerTM virus] |
|||
| LL220VA-1 | SBI | >2x10^6 IFUs | EUR 810 |
pLL-EF1a-Luciferase-T2A-Puro [Lenti-LabelerTM plasmid] |
|||
| LL250PA-1 | SBI | 10 ug | EUR 810 |